Actively Recruiting
Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients
Led by Sohag University · Updated on 2024-10-08
55
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Systemic Lupus Erthymatosous (SLE) is achronic inflammatory multi system auto immue disease characterized by pathogenic auto anti bodies production against nuclear structures (Bolouri et al.,2022), SLE affecting mainly woemn of childbearing age and is chracterized by unpredictable flares and remissions , disease variety varied from mild episode disorder to arpidly progressive life -threatening illness.. LN is diagnosed by either the presence of proteinuria \>0.5g/day. active urinary sediment , or an unexplained rise in serum creatinine there fore , identifying new invasive biomarkers of LN severity and outcome is mandatory, Renal Arterial resistive index ( RRI) is anon invasive biomarker that has been studied as apotential indicator of disease activity in LN patients.
CONDITIONS
Official Title
Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- Diagnosed with Systemic Lupus Erythematosus (SLE) meeting SLICC classification criteria
- Able to cooperate and answer questions
- Able and willing to provide written informed consent
You will not qualify if you...
- Having other autoimmune diseases
- Diabetes
- Hypertension
- Heart failure
- Liver diseases
- Chronic renal failure
- Renal artery stenosis
- Renal vein thrombosis
- Intrarenal arteriovenous fistula
- Obstructive nephropathy
- Urinary tract obstruction affecting renal artery resistive index
- Unable to cooperate
- Unable or unwilling to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sohag university Hospital
Sohag, Egypt, Sohag
Actively Recruiting
Research Team
D
Doaa R Abdelkarim, resident
CONTACT
E
Esam M Abualfadl, professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here